Effect of high energy shock waves on human spermatozoa in vitro

Impact of extracorporeal shockwave therapy for erectile dysfunction and peyronie's disease on reproductive and hormonal testicular function

Introduction

Extracorporeal shock wave therapy is an established treatment for erectile dysfunction and Peyronie's disease. Concerns regarding the safety of extracorporeal shock wave therapy for andrological purposes on testicular function were raised by animal studies.

Aim

To evaluate the impact of extracorporeal shock wave therapy for erectile dysfunction or Peyronie's disease on reproductive and hormonal testicular function.

Methods

We designed a prospective controlled study in which consecutive patients were enrolled. Males aged between 18 and 40 years with mild vasculogenic erectile dysfunction or acute inflammatory Peyronie's disease and normozoospermia were included. All enrolled patients were offered extracorporeal shock wave therapy, and subjects who refused extracorporeal shock wave therapy for any reason were considered as the Control group. All patients in the Intervention group were treated with DUOLITH SD1 T‐TOP by a single expert urologist. Semen analysis and serum total testosterone dosage were performed before the start (T0) and 3 months after the end of extracorporeal shock wave therapy (T1) in Intervention group. The same parameters were evaluated after the extracorporeal shock wave therapy refusal (T0) and at the end of the following 3 months (T1) in Control group. Normozoospermia was chosen as the primary outcome, serum total testosterone concentration was selected as the secondary outcome.

Results

A total of 94 patients were enrolled in the study (48 Group A, 46 Group B). At T0, all patients were normozoospermic in both groups (p = 0.563), and no significant difference in mean ± SD total testosterone levels was recorded between the groups (582.5 ± 107.2 vs. 634.6 ± 108.4 ng/dl; p = 0.221). At T1, no significant deterioration (p > 0.05) in semen parameters was recorded in both groups. Only a statistically significant reduction in seminal pH was found after extracorporeal shock wave therapy compared to baseline (7.9 ± 0.3 vs. 7.5 ± 0.2; p < 0.001) and untreated patients (7.8 ± 0.2 vs. 7.5 ± 0.2; p < 0.001). No significant difference in total testosterone levels was recorded in Intervention group after extracorporeal shock wave therapy compared to baseline (p = 0.584).

Conclusion

Extracorporeal shock wave therapy in erectile dysfunction and Peyronie's disease patients does not seem to affect reproductive and hormonal testicular function.

What is the impact of extracorporeal shock wave lithotripsy on semen parameters? A systematic review and meta-analysis

BACKGROUND

Extracorporeal shock wave lithotripsy (ESWL) is an important tool for the management of urolithiasis. The effects of shockwaves on tissues are established. The aim of this meta-analysis is to evaluate the microscopic semen characteristics of young men before and after ESWL treatment for lower ureteral calculi.

METHODS

Literature searches were performed following the Cochrane guidelines. We conducted a systematic review and meta-analysis that included six trials that investigated the effects of ESWL on semen parameters, including sperm concentration, motility, and hematospermia. Meta-analyses were performed using fixed and random-effects models with tests for publication bias and heterogeneity.

RESULTS

Significant worsening was detected in sperm concentration and motility after ESWL between case and control groups (mean difference -17.23, 95% confidence interval -22.53 to -11.93, p&lt;0.00001, mean difference -10.82, 95% confidence interval -18.56 to -3.07, p = 0.006). Rate of microscopic and macroscopic hematospermia was significantly higher after ESWL between case and control groups [risk ratio (RR) 40.00, 95% confidence interval 10.11-158.30, p&lt;0.00001, RR 14.33, 95% confidence interval 2.82-72.90, p = 0.001]. All parameters recovered after 3 months.

CONCLUSIONS

This study showed sperm concentration, motility, and rate of hematospermia (microscopic and macroscopic) were affected by ESWL that was used for the treatment of lower ureteral stone. Long-term studies with a focus on male fertility (i.e., pregnancy rates) after ESWL are warranted.

ULTRASTRUCTURAL CHANGES ON SPERM AFTER EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY IN PATIENTS WITH DISTAL URETERAL STONE

Theoretically, ESWL can cause several side effects on the male reproductive system. We determined here the long-term effects of ESWL on sperm with transmission electron microscopy (TEM) in patients with distal ureteral stone. Fifteen men with stones in the distal ureter applied to our clinic formed the group of study. The other 15 men with renal or upper ureter stones formed the group of control. The ESWL sessions, including maximum 19 kW energy level and 3000 shock waves, were performed with Siemens Lithostar (electromagnetic; Siemens Medical Systems, Erlangen, Germany) lithotriptor. We examined the semen samples from all patients on the day before and 90 days after ESWL. The semen samples were examined with transmission electron microscopy (TEM) to detect ultrastructural changes on the day before and 90 days after ESWL. All the statistical analyses were realized with SPSS 10.0 (SPSS Inc., Chicago, USA) statistical package program. When the control and study groups were compared for initial and day 90 sperm concentration and motility, a significant decrease was found in the study group. Although there was no important anomaly in the control group, we determined some damage on sperm structure in 5 patients (33.3%) who are in the study group 3 months after ESWL. It can reduce sperm concentration and motility permanently. It can also cause severe ultrastructural defects on sperm after a long term period in patients with lower ureteral stone. Therefore, we suggest other treatment modalities for young men with distal ureteral stones to prevent the development of male infertility.

Relationship between extracorporeal shock wave lithotripsy and semen parameters in patients with lower ureteral stones

The objective of this study was to investigate whether extracorporeal shock wave lithotripsy can affect semen parameters in patients with distal ureteral stones. We concluded that extracorporeal shock wave lithotripsy could reduce sperm concentration and motility permanently in men with lower ureteral stones.

Microscopic and biochemical fertility characteristics of semen after shockwave lithotripsy of distal ureteral calculi

PURPOSE

To elucidate the frequency and adversity of the effects of shockwave lithotripsy (SWL) on the male reproductive system. We investigated the possible alterations in the quality of semen in patients treated by SWL for pelvic ureteral stones.

PATIENTS AND METHODS

The semen of 10 men was examined 1 day before and 5 and 90 days after SWL for distal ureteral stones, in accordance with the World Health Organisation guidelines. The results were compared with those from the semen samples of 10 healthy male volunteers undergoing SWL for calculi of the upper urinary tract.

RESULTS

Microscopic analysis of the semen samples revealed a transient decline in sperm density (24.7%), sperm motility (10%), sperm vitality (8%), and seminal fructose (27.5%) after SWL for distal ureteral stones. A distinctly higher number of spermatozoa of pathological origin was detected after SWL in the same group. There was no trace of microscopic hemospermia before shockwave treatment, but it was detected in 90% of the patients with lower ureteral calculi after SWL. Macroscopic hemospermia was detected in two of these nine patients. No deterioration of the semen characteristics and no hemospermia was observed after treatment in the control group with upper urinary stones.

CONCLUSIONS

Our investigations confirmed a transient deterioration in semen quality after SWL for distal ureteral calculi, whereas no deterioration was observed after SWL for upper ureteral stones. Impaired sperm quality values returned to normal within 12 weeks after SWL, clearly indicating a damaging effect of SWL on seminal vesicle or ejaculatory duct function. The initial procreative capacity was restored in all patients.

Extracorporeal shock wave lithotripsy of renal calculi during early pregnancy

OBJECTIVE

To evaluate the safety of renal stone treatment by extracorporeal shock wave lithotripsy (ESWL) during pregnancy.

PATIENTS AND METHODS

Data from 824 women of reproductive age who were treated by ESWL were analysed and the patients surveyed using a questionnaire about pregnancies, to which 636 (76%) responded. Of these patients, six had inadvertently undergone ESWL for renal stones during the first month of pregnancy. The stones were detected and located during ESWL using ultrasonography.

RESULTS

The six patients gave birth to six children who had no detectable malformations or chromosomal anomalies.

CONCLUSION

Although these results suggest that there were no adverse effects of ESWL during early pregnancy, a larger series should be assessed to confirm the safety and long-term effects of ultrasound-guided ESWL in the treatment of renal calculi during pregnancy. We do not advocate lithotripsy as a treatment for renal calculi in pregnancy, but inadvertent lithotripsy in a pregnant woman is not a cause for concern.

Effects of shock waves on the mouse fetus

Extracorporeal shock wave lithotripsy is contraindicated during pregnancy because its effects on the fetus remain to be ascertained. The purpose of this study was to elucidate the effects of shock waves on fetuses at various stages of pregnancy. Pregnant mice received 100, 250, or 500 shock waves on 8, 10, 12, 14, and 16 days postcoitum. The effect on fetal survival rate and weight was minimal in the early stages of pregnancy. In the later stages of pregnancy, however, the number of viable fetuses decreased in proportion to an increasing number of shock waves, and almost no viable fetuses were found in the group treated with 500 shock waves. Fusion and necrosis were found in many dead fetuses. Histological examination of the fetuses, which was obtained immediately after the shock wave treatment, revealed hemorrhages in the brain, lungs and subcutaneous tissue. This study indicated that shock waves lead to fetal damage and death in the late stage of pregnancy in mice.

High-energy shock waves: in vitro effects

To date, there have been multiple studies on the effects of high-energy shock waves (HESW) on benign and malignant cells under in vitro conditions. The major problem in comparing and contrasting these studies has been the wide range of mechanical, biological, and analytical variables facing the investigator. However, if one takes the time to select out only those studies in which a wide range of experimental variables have been defined or controlled, then it becomes possible to begin to understand the effects of HESW on cells in vitro. With this in mind, the literature has been thoroughly reviewed. It would appear that HESW do cause cellular damage regardless of the cell's doubling time. The cell damage is likely due to the impact of cavitation and the attendant shear forces and jets that are produced by the shock waves as it passes through the cell suspension. The damage occurs both at the cell membrane and within the cell itself. With regard to the latter, it would appear that the mitochondria are most sensitive to HESW; however, damage also occurs within the nucleus and along the endoplasmic reticulum and in other cell organelles (eg, lyosomes). Applications of HESW to other clinical situations are currently being studied. One example of interest is the in vitro combination of chemotherapeutic agents and HESW to enhance the effect of a specific chemotherapeutic regimen on a given tumor cell line. Several investigators have noted a beneficial effect of this combination therapy in vitro; however, similar favorable results have not been obtained when the same or similar tumor system was studied in vivo.